Syverson Strege & CO Novo Cure LTD Call Options Transaction History
Syverson Strege & CO
- $274 Million
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NVCR
# of Institutions
267Shares Held
77.2MCall Options Held
751KPut Options Held
293K-
Black Rock Inc. New York, NY12.1MShares$205 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA11.7MShares$198 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.1MShares$188 Million0.0% of portfolio
-
State Street Corp Boston, MA3.01MShares$50.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.38MShares$40.1 Million0.0% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.77B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...